Top Cancer Biomarkers Companies

Cancer biomarkers providers around the world are estimated to focus on research to maximize their business potential and stay competitive. Developing new therapeutics for specific cancer indications will also be a preferred strategy for new as well as leading cancer biomarkers companies. Market players can also benefit from government support to take their oncology research capabilities to the next level. Use of advanced drug discovery and development techniques will also be popular among cancer biomarker providers in the future.

The scope for innovation in biotechnology is limitless, which is why multiple startups are working in this industry. High funding availability of oncology R&D has helped cancer biomarker startups to stand out from the competition. Here’s a startup that could change the future of oncology and biomarker testing.

• Elypta: This Swedish biotech startup is focused on developing metabolic-based liquid biopsies for early cancer detection and recurrence monitoring. Its proprietary platform uses glycosaminoglycan (GAG) profiling as a novel biomarker signature. Founded in 2017, the company targets cancers with limited biomarker options, such as kidney and liver cancer. The company is advancing clinical trials and has received EU Horizon 2020 and EIC funding. Elypta’s approach offers a unique, cost-effective, and highly specific biomarker solution, positioning it as a promising player in next-generation oncology diagnostics. In March 2025, the company announced the early results of a study which depicted that the company’s urine test has been able to accurately identify 90% of patients with recurrent kidney cancer.

Top Player’s Company Profiles

• F. Hoffmann-La Roche Ltd. (Switzerland)

• Thermo Fisher Scientific Inc. (US)

• Qiagen (Netherlands)

• Bio-Rad Laboratories, Inc. (US)

• Illumina, Inc. (US)

• Agilent Technologies, Inc. (US)

• Abbott Laboratories (US)

• BioMerieux (France)

• Merck KGaA (Germany)

• Becton, Dickinson and Company (US)

• Myriad Genetics, Inc. (US)

• Sysmex Corporation (Japan)

• Hologic, Inc. (US)

• Quest Diagnostics (US)

• Centogene N.V. (Germany)

• BioGenex (US)

• Siemens Healthineers (Germany)

• Exact Sciences (US)

• R&D Systems, Inc. (US, part of Bio-Techne)

• Biovision Inc. (US)

• Olink (Sweden)

• Meso Scale Diagnostics, LLC (US)

• Invivoscribe, Inc. (US)

• INOVIQ Ltd. (Australia)